Evidence map›Paper›PMID 11602736›Full record

ArticleJournal of virology2001

Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.

J L Dzuris, J Sidney, H Horton, R Correa, D Carter, R W Chesnut, D I Watkins, A Sette

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Designing peptide-based HIV vaccine for Chinese.BioMed research international · 2014
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

J L DzurisEpimmune, Inc., San Diego, California 92121, USA.
J Sidney
H Horton
R Correa
D Carter
R W Chesnut
D I Watkins
A Sette
Autoimmune Technologies (United States) · USUniversity of Wisconsin–Madison · US

Funding

ZOLEDRONATE PREVENTS BONE LOSS IN OVARIECTOMIZED RHESUS MONKEYSP51RR000167 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 1985 to 2011
$106.7M
NONVIRAL DELIVERY OF SIV VACCINESP01AI048238 · NIAID · IDM PHARMA, INC. · PI NEWMAN, MARK J. · 2000 to 2003
$4.3M
BAA-APPLICATION OF HLA DATA TO DEVELOP &IMPROVE VACCINEN01AI095362 · NIAID · IDM PHARMA, INC. · PI SETTE, ALESSANDRO · 1999 to 2000
$449k
QUANTITATION OF T CELL RESPONSES TO VACCINATIONR21AI045461 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI WATKINS, DAVID I · 1999 to 2000
$273k
PEPTIDE BASED VACCINE FOR PRIMATE MODEL OF AIDSR44AI038081 · NIAID · IDM PHARMA, INC. · PI CHESNUT, ROBERT W · 1998 to 1999
–
NCRR NIH HHS P51 RR000167NCRR NIH HHS RR00167NIAID NIH HHS 2 R44 AI38081-03NIAID NIH HHS N01 AI095362NIAID NIH HHS N01-AI-95362NIAID NIH HHS P01 AI048238NIAID NIH HHS R01 AI48238-01NIAID NIH HHS R21 AI45461PHS HHS R01 A141913
6 · The paper itself

Abstract

Major histocompatibility complex class II molecules encoded by two common rhesus macaque alleles Mamu-DRB1*0406 and Mamu-DRB*w201 have been purified, and quantitative binding assays have been established. The structural requirements for peptide binding to each molecule were characterized by testing panels of single-substitution analogs of the two previously defined epitopes HIV Env242 (Mamu-DRB1*0406 restricted) and HIV Env482 (Mamu-DRB*w201 restricted). Anchor positions of both macaque DR molecules were spaced following a position 1 (P1), P4, P6, P7, and P9 pattern. The specific binding motif associated with each molecule was distinct, but largely overlapping, and was based on crucial roles of aromatic and/or hydrophobic residues at P1, P6, and P9. Based on these results, a tentative Mamu class II DR supermotif was defined. This pattern is remarkably similar to a previously defined human HLA-DR supermotif. Similarities in binding motifs between human HLA and macaque Mamu-DR molecules were further illustrated by testing a panel of more than 60 different single-substitution analogs of the HLA-DR-restricted HA 307-319 epitope for binding to Mamu-DRB*w201 and HLA-DRB1*0101. The Mamu-DRB1*0406 and -DRB*w201 binding capacity of a set of 311 overlapping peptides spanning the entire simian immunodeficiency virus (SIV) genome was also evaluated. Ten peptides capable of binding both molecules were identified, together with 19 DRB1*0406 and 43 DRB*w201 selective binders. The Mamu-DR supermotif was found to be present in about 75% of the good binders and in 50% of peptides binding with intermediate affinity but only in approximately 25% of the peptides which did not bind either Mamu class II molecule. Finally, using flow cytometric detection of antigen-induced intracellular gamma interferon, we identify a new CD4(+) T-lymphocyte epitope encoded within the Rev protein of SIV.

Indexed as

Amino Acid SequenceAnimalsEpitopesHIVHLA-DR AntigensHLA-DRB1 ChainsMacaca mulattaMolecular Sequence DataPeptide FragmentsSimian Immunodeficiency VirusViral Envelope ProteinsEpitopesHLA-DR AntigensHLA-DRB1 ChainsPeptide FragmentsViral Envelope Proteins

Identifiers

PMID11602736
PMCPMC114676
OpenAlexW2100856106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.